Amgen (AMGN) awards 730-share RSU grant to VP Finance & CAO Busch
Rhea-AI Filing Summary
Busch Matthew C. reported acquisition or exercise transactions in this Form 4 filing.
Amgen Inc. reported that officer Matthew C. Busch, VP, Finance & CAO, received an equity compensation award of 730 shares of Common Stock in the form of Restricted Stock Units (RSUs) on 2026-08-07. The RSUs were granted under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vest in four equal annual installments of 25%, beginning on 8/7/2027. Vested RSUs will be settled in shares of Amgen common stock on a one-to-one basis. Following this award, Busch holds 5,080 shares directly, which include 45 Dividend Equivalents (DEs) credited to his unvested RSUs.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 730 shares
Net Buy
1 txn
Insider
Busch Matthew C.
Role
VP, Finance & CAO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1, F2 | 730 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 5,080 shares (Direct)
Footnotes (2)
- F1. The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 8/7/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
- F2. These shares include 45 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Key Figures
RSU shares granted: 730 shares
Post-award holdings: 5,080 shares
Dividend Equivalents included: 45 DEs
+2 more
5 metrics
RSU shares granted
730 shares
Restricted Stock Units granted on 2026-08-07 as equity award
Post-award holdings
5,080 shares
Total Amgen common shares directly held by Matthew C. Busch after transaction
Dividend Equivalents included
45 DEs
DEs credited to unvested RSUs and included in reported share total
Vesting schedule
25% annually over four years
RSUs vest in four equal annual installments starting 8/7/2027
Vesting commencement date
8/7/2027
Date first 25% installment of RSUs is scheduled to vest
Key Terms
Restricted Stock Units (RSUs), Dividend Equivalents (DEs), Equity Incentive Plan, qualifying dividend reinvestment plan
4 terms
Restricted Stock Units (RSUs) financial
"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended..."
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Dividend Equivalents (DEs) financial
"These shares include 45 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan..."
Equity Incentive Plan financial
"granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan..."
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
qualifying dividend reinvestment plan financial
"DEs granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan."
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity award did Amgen (AMGN) grant to Matthew C. Busch?
Amgen granted 730 RSU-based Common Stock shares to Matthew C. Busch on 2026-08-07 under its Equity Incentive Plan. The RSUs vest in four equal 25% annual installments starting 8/7/2027 and are settled in Amgen common stock.
How do the new RSUs for Amgen (AMGN) executive Matthew C. Busch vest?
The RSUs vest in four equal annual installments of 25%, beginning on 8/7/2027. Each vested portion will be paid out in Amgen common stock on a one-to-one basis, aligning the executive’s compensation with share performance over time.
What are Dividend Equivalents (DEs) in the Amgen (AMGN) Form 4 for Matthew C. Busch?
The filing notes 45 Dividend Equivalents (DEs) credited to Busch’s unvested RSUs under a qualifying dividend reinvestment plan. These DEs are paid in Amgen common stock on a one-to-one basis as the RSUs vest, plus cash for any fractional share amounts.
Under which plan were Matthew C. Busch’s Amgen (AMGN) RSUs granted?
The RSUs were granted under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan. This plan provides equity-based awards like Restricted Stock Units (RSUs) and related Dividend Equivalents (DEs) to align management incentives with shareholder interests.